E02S0207 Rat Sclerostin ELISA kit
The Rat Sclerostin ELISA kit can be used to identify samples from the rat species. Sclerostin can also be called CDD, SOST1, VBCH, DAND6, sclerostin, Sclerostin, SOST.
E02S0207 Rat Sclerostin ELISA kit
The Rat Sclerostin ELISA kit can be used to identify samples from the rat species. Sclerostin can also be called CDD, SOST1, VBCH, DAND6, sclerostin, Sclerostin, SOST.
Product Information | |
Cat. No. | E02S0207 |
Product Name | Rat Sclerostin ELISA kit |
Species | Rat |
Product Size | 48 Tests / 96 Tests |
Concentration | 250-5000 pg/mL |
Sensitivity | 1.0 pg/ml |
Principal | Competitive ELISA |
Sample Volume | 100 ul |
Sample Type | Serum, plasma, cell culture supernatants, body fluid and tissue homogenate |
Assay Time | 90 minutes |
Platform | Microplate Reader |
Conjugate | HRP |
Detection Method | Colorimetric |
Storage | 2-8°C |
Kit Components | ||
MATERIALS | SPECIFICATION | QUANTITY |
MICROTITER PLATE | 96 wells | stripwell |
ENZYME CONJUGATE | 6.0 mL | 1 vial |
STANDARD A (0.5mL) | 0 pg/mL | 1 vial |
STANDARD B (0.5mL) | 250 pg/mL | 1 vial |
STANDARD C (0.5mL) | 500 pg/mL | 1 vial |
STANDARD D (0.5mL) | 1000 pg/mL | 1 vial |
STANDARD E (0.5mL) | 2500 pg/mL | 1 vial |
STANDARD F (0.5mL) | 5000 pg/mL | 1 vial |
SUBSTRATE A | 6 mL | 1 vial |
SUBSTRATE B | 6 mL | 1 vial |
STOP SOLUTION | 6 mL | 1 vial |
WASH SOLUTION (100 x) | 10 mL | 1 vial |
BALANCE SOLUTION | 3 mL | 1 vial |
Principle of the Assay |
SOST ELISA kit uses an anti-SOST antibody and an SOST-HRP conjugate in a competitive enzyme immunoassay method. SOST-HRP conjugate is incubated with the assay sample and buffer in a pre-coated plate for one hour. The wells are decanted and washed five times when the incubation period is over. The HRP enzyme substrate is then incubated in the wells. The result of the enzyme-substrate reaction is a complex that is blue in hue. The process is finally stopped by adding a stop solution, causing the solution to turn yellow. In a microplate reader, the color intensity is measured spectrophotometrically at 450 nm. Due to competition for the anti-SOST antibody binding site between SOST from samples and SOST-HRP conjugate, the intensity of the color is inversely proportional to the concentration of SOST. Since the number of sites is limited, as more sites are occupied by SOST from the sample, fewer sites are left to bind SOST-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The SOST concentration in each sample is interpolated from this standard curve. |
Coefficient of Variance | Intra Variation% <10% | |
Inter Variation% <12% | ||
Recovery | 95-102% | |
Linearity | Diluent Ratio | Range % |
1:2 | 93-105 | |
1:4 | 88-106 | |
1:8 | 86-108 | |
Specificity/Cross-reactivity | No significant cross-reactivity or interference between SOST and analogues was observed. |
E02S0207 has been referenced in the below publications:
The effect of lamotrigine and phenytoin on bone turnover and bone strength: A prospective study in Wistar rats.
Related Bluegene Biotech Products
BlueGene Biotech News